Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02671604
Other study ID # GK9
Secondary ID
Status Completed
Phase N/A
First received January 21, 2016
Last updated January 31, 2016
Start date January 2014
Est. completion date January 2015

Study information

Verified date January 2016
Source Umraniye Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Observational [Patient Registry]

Clinical Trial Summary

In patients undergoing robot-assisted radical prostatectomy (RARP), pneumoperitoneum, intraoperative fluid restriction and prolonged Trendelenburg position may cause rhabdomyolysis (RM) due to hypoperfusion in gluteal muscles and lower extremities.

In this study, it was aimed to assess effects of BMI, comorbidities, intraoperative positioning, fluid restriction and length of surgery on development of RM in RARP patients during perioperative period.


Description:

Fifty-two ASA I-II patients aged 50-80 years, BMI >25 kg/m2 scheduled for an elective RARP were enrolled to the study.

In all patients, pre-anesthetic evaluations including laboratory tests and Charlson Comorbidity Index (CCI) were performed one week before surgery in anesthesia clinic. Comorbid diseases were rated based on CCI. A 4-points scale was used to rate comorbid conditions [1 mild; 4 severe]. Comorbidity grading was performed by adding scores given for each comorbid disease. Based on the grading, patients were stratified into 4 groups as follows: grade 0, 1-2, 3-4 and ≥ 5

In the operation room, intubation was performed after standard anesthesia For surgery, patients were placed in low lithotomy position. All patients were placed on a soft sponge mattress and soft padding gel pads were provided above the shoulders. The patients were placed in a 30-degree STP after achieving pneumoperitoneum at an intra-abdominal pressure level of 15 mmHg. After placing patient to desired position (T0), blood samples were drawn for measurements of ABG, Na, Cl, Ca, K, BUN, Cr, AST, ALT, LDH, cTp-I, CK-MB and CPK.

During the operation, normal saline (1 m/kg/hr) and 6% HES 200/05 (1 ml/kg/hr) infusions were applied. Operation time (OT) and Trendelenburg time (TT) were recorded in all patients.

Blood samples were repeated on the hours 6 (T6), 12 (T12) and 24 (T24) after beginning of surgery. Hydration with 2000 ml crystalloid solution was given until hour 24 after surgery. In all patients, urine output was monitored.

Rhabdomyolysis was defined as postoperative serum CPK level exceeding 5,000 IU/L. It was planned to manage these patients with hypervolemic therapy, correction of acidosis by using IV sodium bicarbonate and stimulation of diuresis by IV furosemide with a goal of maintaining minimal diuresis of 60 ml/hr at pH level of 7.

Postoperative RF was defined as an increase in serum creatinine of 1mg/dl/day (or 90 mmol/l/day) for 2 consecutive days beyond the baseline.

Patients were discharged with control laboratory tests, including the same parameters, on the hour 48 (T48) postoperatively.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria:

- ASA I-II

- Aged 50-80 years,

- BMI >25 kg/m2

- Patients scheduled for an elective RARP

Exclusion Criteria:

- Patients with ASA III-IV risk status,

- Patients with comorbid diseases that can cause increased muscular activity such as severe dystonia or status asthmaticus,

- Patients with renal or hepatic failure and patients on statin or steroid therapy were excluded.

- Patients converted to laparotomy during surgery.

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey gulsah Karaoren Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Umraniye Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Kim TK, Yoon JR, Lee MH. Rhabdomyolysis after laparoscopic radical nephrectomy -A case report-. Korean J Anesthesiol. 2010 Dec;59 Suppl:S41-4. doi: 10.4097/kjae.2010.59.S.S41. Epub 2010 Dec 31. — View Citation

Vijay MK, Vijay P, Kundu AK. Rhabdomyolysis and myogloginuric acute renal failure in the lithotomy/exaggerated lithotomy position of urogenital surgeries. Urol Ann. 2011 Sep;3(3):147-50. doi: 10.4103/0974-7796.84965. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With serumCreatine Phosphokinase Values greater than 5000IU/L Rhabdomyolysis was defined as postoperative serum Creatine Phosphokinase level exceeding 5000 IU/L. Change from Baseline Creatine Phosphokinase at 24 hours. No
Secondary number of patients with abnormal laboratory values Laboratory values of serum Na, Cl, Ca, K, BUN, Cr, AST, ALT, LDH, cTp-I, CK-MB on the hours 0 (T9), 6 (T6), 12 (T12) and 24 (T24) after beginning of surgery. No
See also
  Status Clinical Trial Phase
Completed NCT03737513 - Exercise-induced Collective Rhabdomyolysis
Completed NCT00241748 - Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event N/A
Not yet recruiting NCT02498366 - Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty N/A
Not yet recruiting NCT06429982 - Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols Phase 1
Active, not recruiting NCT06101680 - RhabdomYolyse in Intensive caRe
Withdrawn NCT02896517 - Support for the Rhabdomyolysis in an Emergency Department
Completed NCT01467180 - Myoglobin Removal by High Cut-off CVVHD N/A
Recruiting NCT01022450 - Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients N/A
Completed NCT00391911 - Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis Phase 2
Withdrawn NCT02111018 - Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis Phase 2
Completed NCT04913298 - Prospective Study for the Application of Cytosorb® in Critically Ill Patients N/A
Recruiting NCT05146336 - CytOSorb TreatMent Of Critically Ill PatientS Registry
Completed NCT03986736 - Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
Not yet recruiting NCT02518724 - The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis N/A
Completed NCT00592657 - Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions N/A
Completed NCT06338423 - Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure N/A
Completed NCT01976936 - Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 Phase 2
Completed NCT04118608 - Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment
Completed NCT01544231 - Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis N/A
Recruiting NCT00549029 - The Association of Genetic Polymorphisms With Statin-Induced Myopathy. N/A